Compare BVS & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BVS | AHCO |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | 950 | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 910.2M | 752.4M |
| IPO Year | 2016 | 2017 |
| Metric | BVS | AHCO |
|---|---|---|
| Price | $13.38 | $5.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $17.60 | $8.86 |
| AVG Volume (30 Days) | 371.8K | ★ 2.0M |
| Earning Date | 11-02-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 163.46 | N/A |
| EPS | ★ 0.52 | N/A |
| Revenue | $568,087,000.00 | ★ $3,244,857,000.00 |
| Revenue This Year | $6.46 | N/A |
| Revenue Next Year | $6.74 | $3.80 |
| P/E Ratio | $28.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.47 | $5.21 |
| 52 Week High | $15.89 | $13.43 |
| Indicator | BVS | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 45.53 |
| Support Level | $13.44 | $5.70 |
| Resistance Level | $14.33 | $5.95 |
| Average True Range (ATR) | 0.55 | 0.26 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 19.26 | 22.88 |
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.